The WACC of Talis Biomedical Corp (TLIS) is 5.5%.
| Range | Selected | |
| Cost of equity | 5.90% - 8.90% | 7.40% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 4.8% - 6.3% | 5.5% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.45 | 0.72 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.90% | 8.90% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 4.8% | 6.3% |
| Selected WACC | 5.5% | |